Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1986; Volume 239,Issue 2
  • You have access
    Do calcium antagonists act directly on calcium channels to alter baroreceptor function?
    D L Kunze, M C Andresen and L A Torres
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 303-310;
  • You have access
    Dependence on tetrahydrocannabinol in rhesus monkeys.
    P M Beardsley, R L Balster and L S Harris
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 311-319;
  • You have access
    A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
    S P Welch and W L Dewey
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 320-326;
  • You have access
    Sensitivity and tolerance to ethanol in mice bred to be genetically prone or resistant to ethanol withdrawal seizures.
    J C Crabbe and A Kosobud
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 327-333;
  • You have access
    Increase of cyclic AMP concentrations in cultured vascular smooth muscle cells by vasoactive peptide hormones. Role of endogenous prostaglandins.
    A Hassid
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 334-339;
  • You have access
    The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
    J J Lynch, D G Montgomery and B R Lucchesi
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 340-345;
  • You have access
    Tolerance to morphine effects on renal disposition of xenobiotics in mice.
    M Garty and A Hurwitz
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 346-350;
  • You have access
    Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    S W Tam and L Y Liu-Chen
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 351-357;
  • You have access
    Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
    M J Marks, J A Stitzel and A C Collins
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 358-364;
  • You have access
    Myocardial and vascular actions of amiloride in spontaneously hypertensive rats.
    R J Barrett and S T Kau
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 365-374;
  • You have access
    Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
    J S Hayes, V L Wyss, H C Wilson, D W Robertson and R F Kauffman
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 375-381;
  • You have access
    Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    A P Roszkowski, G L Garay, S Baker, M Schuler and H Carter
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 382-389;
  • You have access
    Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta.
    J Van Dam, Y T Maddox, P W Ramwell and P A Kot
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 390-394;
  • You have access
    Analysis of airway responses to A23187 in the cat.
    T Kriseman, D C Underwood, A L Hyman and P J Kadowitz
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 395-399;
  • You have access
    Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
    T M Lin, D C Evans, M W Warrick and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 400-405;
  • You have access
    Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    T M Lin, D C Evans, M W Warrick and R P Pioch
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 406-410;
  • You have access
    Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.
    G Tsujimoto, C H Lee and B B Hoffman
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 411-415;
  • You have access
    Human coffee drinking: reinforcing and physical dependence producing effects of caffeine.
    R R Griffiths, G E Bigelow and I A Liebson
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 416-425;
  • You have access
    Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
    S Nagahama, Y F Chen, M D Lindheimer and S Oparil
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 426-432;
  • You have access
    Effects of ethylketazocine and morphine on schedule-controlled behavior in pigeons and squirrel monkeys.
    J L Katz and S R Goldberg
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 433-441;
  • You have access
    Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    L P Dwoskin and N R Zahniser
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 442-453;
  • You have access
    Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
    R W Fuller, H D Snoddy and B B Molloy
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 454-459;
  • You have access
    Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro.
    S M Hatfield, B H Petersen and J A DiMicco
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 460-466;
  • You have access
    Biliary excretion of organic anions in diabetic rats.
    J B Watkins and H Noda
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 467-473;
  • You have access
    Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.
    N Katsube, D Schwartz and P Needleman
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 474-479;
  • You have access
    Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
    Z Zukowska-Grojec, M Haass, I J Kopin and N Zamir
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 480-487;
  • You have access
    Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.
    M D Kaniucki, J C Elverdin, M A Luchelli-Fortis, C J Perec and F J Stefano
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 488-493;
  • You have access
    Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle.
    N Ueda, I Muramatsu, T Taniguchi, S Nakanishi and M Fujiwara
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 494-499;
  • You have access
    Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
    S Narumiya and M Fukushima
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 500-505;
  • You have access
    Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
    S Narumiya, K Ohno, M Fujiwara and M Fukushima
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 506-511;
  • You have access
    Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate.
    K Honda and C Nakagawa
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 512-516;
  • You have access
    Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
    H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;
  • You have access
    Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.
    G D'Agostino, H Kilbinger, M C Chiari and E Grana
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 522-528;
  • You have access
    Mechanisms of histamine-induced relaxation in isolated monkey and dog coronary arteries.
    N Toda
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 529-535;
  • You have access
    Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
    I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;
  • You have access
    Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
    A Perio, J P Chambon, R Calassi, M Heaulme and K Biziere
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 542-547;
  • You have access
    Effect of intravenous ferric or aluminum chloride on the uptake of 203Pb into brain and other soft tissues of rats.
    R Deane, S H Park and M W Bradbury
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 548-553;
  • You have access
    Release of acetylcholine mediated by cholecystokinin receptor from the guinea pig sphincter of Oddi.
    T Harada, T Katsuragi and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 554-558;
  • You have access
    Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
    P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;
  • You have access
    Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: blockade by islet-activating protein.
    J Xu and W J Wojcik
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 568-573;
  • You have access
    Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris.
    P H Howe, R A Akhtar, S Naderi and A A Abdel-Latif
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 574-583;
  • You have access
    Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
    Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;
  • You have access
    In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.
    H C Stanton and K W Dungan
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 591-596;
  • You have access
    Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins.
    S E Patton, D M Lapadula and M B Abou-Donia
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 597-605;
  • You have access
    Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons.
    B L Waszczak, E K Lee and J R Walters
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 606-611;
  • You have access
    Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome.
    B Ault, M Gruenthal, D R Armstrong and J V Nadler
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 612-617;
  • You have access
    Action of cholecystokinin octapeptide and CCK-related peptides on neurons in inferior mesenteric ganglion of guinea pig.
    M A Schumann and D L Kreulen
    Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 618-625;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 239, Issue 2
1 Nov 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics